Generic mental‑health apps feel shallow — build evidence‑based, psych‑rooted care

Generic mental‑health apps today often feel shallow because they prioritize engagement mechanics over validated psychotherapeutic content, leaving consumers, employers and clinicians frustrated by low efficacy and retention; the addressable market is roughly 900 million adults willing to spend about $40/yr on higher‑quality digital mental‑health tools, or about $36.0B. People most affected include working adults with mild‑to‑moderate conditions who lack access to timely therapy, HR buyers seeking scalable benefits, and clinicians looking for measurement‑based adjuncts rather than checklists. You could build an evidence‑based, psychotherapy‑rooted digital therapeutic that combines manualized interventions (CBT, DBT, behavioral activation) with LLM‑driven personalization, routine outcome monitoring, and a therapist‑in‑the‑loop escalation pathway, plus APIs for employer and EHR integration. The timing is favorable: AI personalization can materially increase adherence and tailoring, employers are expanding digital mental‑health benefits as a stable B2B channel, and increasing clinical trials and regulatory clarity make buyers more willing to pay; the market fundamentals and trend signals support a market score of 92/100 and revenue potential of 84/100. To stand out you must prioritize clinical validation (peer‑reviewed RCTs or real‑world evidence), transparent AI behavior and strong privacy/compliance, and demonstrate clear ROI for employers; competition is medium, so rigor and integration can be differentiators. Be honest about the challenges: running trials and navigating regulatory pathways costs time and capital, user acquisition and sustained engagement remain hard, and B2B sales cycles are long, but clear clinical outcomes and measurable employer ROI are the most defensible paths to scale.